Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists

References

• Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA. 1998; 280: 605–13
   PubMed Web of Science ®Google Scholar
• Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, et al. Non-cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA. 2002; 288: 58–66
   PubMed Web of Science ®Google Scholar
• Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, , et al; HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA. 2002;288:49–57.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, , et al; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.
   PubMed Web of Science ®Google Scholar
• Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362:419–27.
   PubMed Web of Science ®Google Scholar
• Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med. 2004; 140: 184–8
   PubMed Web of Science ®Google Scholar
• Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol. 2003; 102: 1225–32
   PubMed Web of Science ®Google Scholar
• Estrogen use continues to decrease. In: Third Quarter Report on National Drug Use (in Swedish). The National Board of Health and Welfare Stockholm; 2002. Available online at: http://www.sos.se/FULLTEXT/125/2002-125-18/2002-125-18.htm.
   Google Scholar
• Legemiddelforbruket i Norge (in Norwegian). Available online at: http://www.legemiddelforbruk.no.
   Google Scholar
• Ændringer i forbruget af hormoner til behandling af kvinder med gener i forbindelse med overgangsalderen (in Danish). Available online at: http://www.laegemiddelstyrelsen.dk.
   Google Scholar
• Nilsen ST, Pedersen AT, Moen MH, Milsom I, Mattsson LA, Iversen OE, et al. Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement therapy: a comparison between gynecologists in Denmark, Norway and Sweden. Maturitas. 2001; 39: 83–90
   PubMed Web of Science ®Google Scholar
• Andersson K, Mattsson LA, Milsom I. Use of hormone replacement therapy. Lancet. 1996; 348: 1521
   PubMed Web of Science ®Google Scholar
• Moen MH, Fredriksen T, Nilsen ST, Iversen OE. Use of hormone replacement therapy among female gynecologists and partners of male gynecologists in Norway. Tidsskr Nor Laegeforen. 1998; 118: 2944–6
   PubMedGoogle Scholar
• McNagny SE, Wenger NK, Frank E. Personal use of postmenopausal hormone replacement therapy by women physicians in the United States. Ann Int Med. 1997; 127: 1093–6
   PubMed Web of Science ®Google Scholar
• Isaacs AJ, Britton AR, McPherson K. Why do women doctors in the UK take hormone replacement therapy?. J Epidemiol Commun Health. 1997; 51: 373–7
   PubMed Web of Science ®Google Scholar
• Biglia N, Cozzarella M, Ponzone R, Marenco D, Maggiorotto F, Fuso L, et al. Personal use of HRT by postmenopausal women doctors and doctors’ wives in the north of Italy. Gynecol Endocrinol. 2004; 18: 165–74
   PubMed Web of Science ®Google Scholar
• Moen MH, Nilsen ST, Iversen OE. A significant change in Norwegian gynecologist's attitude to hormone therapy is observed after the results of the Women's Health Initiative Study. Acta Obstet Gynecol Scand. 2005; 84: 92–3
   PubMed Web of Science ®Google Scholar
• Thunell L, Milsom I, Schmidt J, Mattsson LÅ. Scientific evidence changes prescribing practice: a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynecologists in 1996 and 2003. BJOG. 2006; 113: 15–20
   PubMed Web of Science ®Google Scholar
• Levy BT, Ritchie JM, Smith E, Gray T, Zhang W. Physician specialty is significantly associated with hormone replacement therapy use. Obstet Gynecol. 2003; 101: 114–22
   PubMed Web of Science ®Google Scholar
• McNagny SE, Jacobson TA. Use of postmenopausal hormone replacement therapy by African American women. The importance of physician discussion. Arch Intern Med. 1997; 157: 1337–42
   PubMedGoogle Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 1997;350:1047–59.
   PubMed Web of Science ®Google Scholar
• Holmberg L, Anderson H; HABITS Steering and Data Monitoring Committees. HABITS (hormonal replacement therapy after breast cancer – is it safe?), a randomised comparison: trial stopped. Lancet. 2004;363: 453–5.
   Google Scholar
• Farquhar CM, Marjoribanks J, Lethaby A, Lamberts Q, Suckling JA; the Cochrane HT Study Group. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2005;3:CD004143.
   Google Scholar
• Blumel JE, Castelo-Branco C, Chedraui PA, Binfa L, Dowlani B, Gomez MS, et al. Patients’ and clinicians’ attitudes after the Women's Health Initiative study. Menopause. 2004; 11: 57–61
   PubMed Web of Science ®Google Scholar
• Ena G, Rozenberg S. Issues to debate on the Women's Health Initiative (WHI) study. Prescription attitudes among Belgian gynaecologists after premature discontinuation of the WHI study. Hum Reprod. 2003; 18: 2245–8
   PubMed Web of Science ®Google Scholar
• Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, et al. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study. Menopause 2006; 13: 125–9
   PubMed Web of Science ®Google Scholar
• Nassar AH, Essamad HM, Awwad JT, Khoury NG, Usta IM. Gynecologists’ attitudes towards hormone therapy in the post ‘Women's Health Initiative’ study era. Maturitas. 2005; 52: 18–25
   PubMed Web of Science ®Google Scholar
• Neyro JL, Cancelo MJ, Quereda F, Palacios S; NAMS Group of the AEEM. Relevance of the results of the Women's Health Initiative on the prescription of hormone therapy in Spain. Climacteric. 2005;8:36–48.
   PubMed Web of Science ®Google Scholar
• Isaacs AJ, Drew SV, McPherson K. UK women doctors’ use of hormone replacement therapy: 10-year follow up. Climacteric. 2005; 8: 154–61
   PubMed Web of Science ®Google Scholar